The Role of Dynamic CT for the Differential Diagnosis of Solitary Pulmonary Nodule.
10.12701/yujm.2008.25.2.102
- Author:
Jin Hong CHUNG
1
;
Won Jong PARK
;
Ihn Ho CHO
Author Information
1. Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Korea. jhchn@med.yu.ac.kr
- Publication Type:Original Article
- Keywords:
Solitary pulmonary nodule;
Differential diagnosis;
Dynamic CT
- MeSH:
Biopsy, Needle;
Diagnosis, Differential;
Hemodynamics;
Humans;
Injections, Intravenous;
Solitary Pulmonary Nodule
- From:Yeungnam University Journal of Medicine
2008;25(2):102-107
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Malignant pulmonary nodules account for 30 to 40 percent of all solitary pulmonary nodules (SPNs). Therefore, characterization of SPNs is very important for treatment. Recently, dynamic CT has been widely used for tissue characterization and formation of differential diagnoses. The purpose of this study was to evaluate the ability of dynamic CT to formulate the differential diagnosis of SPNs. MATERIALS AND METHODS: Nineteen patients with SPNs underwent dynamic CT (unenhanced scans, followed by a series of images at 20, 40, 60, 80, 100, 120, 140, 160, and 180 sec after intravenous injection of contrast medium). Diagnosis of SPN was performed based on pathologic findings in needle biopsy samples. Peak enhancement, net enhancement, slope of enhancement, and maximum relative enhancement ratio of the SPN were measured on dynamic CT, and Levene's test was performed to assess benignancy and malignancy. RESULTS: Twelve SPNs were confirmed to have malignant pathology. There were no significant differences between benign and malignant nodules with respect to peak enhancement (p=0.787), net enhancement (p=0.135), or slope of enhancement (p=0.698). The maximal enhancement ratio was increased in malignancy compared to benignancy, but the difference was not statistically significant (p=0.094). CONCLUSION: In our study, the hemodynamic characteristics of dynamic CT were not significantly different between benign and malignant nodules. Therefore, long-term studies of larger patient samples are required to confirm our findings.
